-
France set to pass emergency ‘budget law’: is it good or bad for your finances?
The country will effectively be without a budget from 2025, with knock-on effects for individuals and companies
-
EasyJet announces nine new flight routes from France including to UK
A service from Bordeaux to Birmingham is among the new announcements
-
French weekend weather outlook December 14 - 15: gloomy and chilly in the north
Cloudy skies are expected to dominate in the north, but in the south temperatures will still reach double figures
EU law, not Brexit, sped up UK access to Covid vaccine
A closer look at a British minister’s claims that Brexit enabled the UK to be first to offer a vaccine shows that Britain has in fact relied on an EU law, France's public-service media explains
The UK’s health minister claimed in a radio interview that “thanks to Brexit” the UK will be first to start Covid vaccinations.
According to Matt Hancock, Brexit allowed the British regulator to take the authorisation decision so as not to “go at the pace of the Europeans, who are moving a little bit more slowly”.
However it is in fact due to European directive 2001/83/EC, transposed into UK law eight years ago as regulation 174 on medicines, that the fast authorisation was possible.
The approved vaccine is the same Pfizer/BioNTech vaccine that is expected to be shortly available in France. Being made in Germany and Belgium, it is going through a process of authorisation by the European Medicines Agency.
However the UK has bypassed this stage by relying on an EU law which allows a member state to temporarily authorise use of a non-approved medicine in a health emergency.
The use of an EU rule is confirmed on gov.uk, which stated last month: “Until the end of December, and as part of the transition period, vaccines must be authorised via the European Medicines Agency and that authorisation will automatically be valid in the UK.
"However, if a suitable COVID-19 vaccine candidate, with strong supporting evidence of safety, quality and effectiveness from clinical trials becomes available before the end of the transition period, EU legislation which we have implemented via Regulation 174 of the Human Medicines Regulations allows the MHRA [UK medicines regulator] to temporarily authorise the supply of a medicine or vaccine, based on public health need.”
The discrepancy was picked up by French state media FranceInfo, which said that “the British medicines agency could have taken its decision to authorise a vaccine against Covid-19, whether or not the country was a member of the EU".
Until December 31, due to the Brexit transition period, the UK must continue to follow all EU laws.
Previous articles
France's PM says free Covid vaccine ready within weeks
France targets vaccine roll-out to wider public from April
Covid vaccine roll-out ready in France for January